BSE - Delayed Quote INR

FDC Limited (FDC.BO)

456.90 +4.15 (+0.92%)
At close: 3:28 PM GMT+5:30
Loading Chart for FDC.BO
DELL
  • Previous Close 452.75
  • Open 452.80
  • Bid 456.85 x --
  • Ask 456.85 x --
  • Day's Range 450.00 - 459.45
  • 52 Week Range 281.40 - 487.50
  • Volume 6,353
  • Avg. Volume 16,639
  • Market Cap (intraday) 74.388B
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) 25.74
  • EPS (TTM) 17.75
  • Earnings Date May 23, 2024 - May 27, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Mar 19, 2020
  • 1y Target Est 280.00

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Ziglim Plus 2, Vitcofol, Pyrimon DF, Zocon, Zoxan, Zathrin, Zipod, Amodep-AT, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Electral, Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. The company was founded in 1936 and is headquartered in Mumbai, India.

www.fdcindia.com

6,372

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: FDC.BO

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FDC.BO
15.36%
S&P BSE SENSEX
2.91%

1-Year Return

FDC.BO
52.17%
S&P BSE SENSEX
23.78%

3-Year Return

FDC.BO
49.07%
S&P BSE SENSEX
55.27%

5-Year Return

FDC.BO
179.86%
S&P BSE SENSEX
90.35%

Compare To: FDC.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FDC.BO

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    73.71B

  • Enterprise Value

    70.11B

  • Trailing P/E

    25.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.88

  • Price/Book (mrq)

    3.74

  • Enterprise Value/Revenue

    3.67

  • Enterprise Value/EBITDA

    16.73

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.12%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    19.16B

  • Net Income Avi to Common (ttm)

    2.9B

  • Diluted EPS (ttm)

    17.75

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.83B

  • Total Debt/Equity (mrq)

    1.25%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: FDC.BO

Analyst Price Targets

280.00 Low
280.00 Average
456.90 Current
280.00
 

Earnings

Consensus EPS
 

Company Insights: FDC.BO

People Also Watch